SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-249879
Filing Date
2017-08-07
Accepted
2017-08-07 16:10:06
Documents
9
Period of Report
2017-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d439454d8k.htm 8-K 63289
2 EX-3.1 d439454dex31.htm EX-3.1 4827
3 EX-10.1 d439454dex101.htm EX-10.1 71488
4 EX-10.2 d439454dex102.htm EX-10.2 274673
5 EX-10.3 d439454dex103.htm EX-10.3 140763
6 EX-10.4 d439454dex104.htm EX-10.4 71255
7 EX-10.7 d439454dex107.htm EX-10.7 581704
8 EX-99.1 d439454dex991.htm EX-99.1 13617
9 GRAPHIC g439454g58x14.gif GRAPHIC 3777
  Complete submission text file 0001193125-17-249879.txt   1228635
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 171011589
SIC: 2834 Pharmaceutical Preparations